Dyspnea News and Research

RSS
Dyspnea or dyspnoea or shortness of breath is a debilitating symptom that is the experience of unpleasant or uncomfortable respiratory sensations.

Further Reading

NMES may reduce muscle atrophy in patients with severe COPD: Researchers

NMES may reduce muscle atrophy in patients with severe COPD: Researchers

STOP AF trial: Arctic Front Cardiac CryoAblation Catheter System reduces AF symptoms by 80%

STOP AF trial: Arctic Front Cardiac CryoAblation Catheter System reduces AF symptoms by 80%

Forest, Almirall to present data on aclidinium bromide for COPD and LAS100977 for asthma at ATS conference

Forest, Almirall to present data on aclidinium bromide for COPD and LAS100977 for asthma at ATS conference

Sucampo presents phase 3 trial results of lubiprostone in non-cancer pain patients with OBD at DDW 2010

Sucampo presents phase 3 trial results of lubiprostone in non-cancer pain patients with OBD at DDW 2010

Ferring to acquire global rights to Xanodyne Pharmaceutical's LYSTEDA

Ferring to acquire global rights to Xanodyne Pharmaceutical's LYSTEDA

Takeda enters co-promotion agreement with Janssen Pharma for VELCADE

Takeda enters co-promotion agreement with Janssen Pharma for VELCADE

Allos Therapeutics reports net loss of $20.5 million for first-quarter 2010

Allos Therapeutics reports net loss of $20.5 million for first-quarter 2010

Data from Phase IV study of Bystolic tablets in Hispanic patients with hypertension presented at ASH 2010

Data from Phase IV study of Bystolic tablets in Hispanic patients with hypertension presented at ASH 2010

New data on Cimzia for Crohn’s Disease treatment to be demonstrated at DDW 2010

New data on Cimzia for Crohn’s Disease treatment to be demonstrated at DDW 2010

PROVENGE receives FDA approval for treatment of CRPC

PROVENGE receives FDA approval for treatment of CRPC

High incidence of MDS among seniors, elderly at increased risk of premature death: Study

High incidence of MDS among seniors, elderly at increased risk of premature death: Study

Data from Phase 2 clinical trials of Hematide/peginesatide presented at NKF Annual Meeting

Data from Phase 2 clinical trials of Hematide/peginesatide presented at NKF Annual Meeting

Genzyme presents 4-year follow-up data from Phase 2 MS trial at neurology meeting

Genzyme presents 4-year follow-up data from Phase 2 MS trial at neurology meeting

Alkermes submits VIVITROL sNDA for opioid dependence

Alkermes submits VIVITROL sNDA for opioid dependence

FDA approves TachoSil adjunctive hemostatic agent for use in cardiovascular surgery

FDA approves TachoSil adjunctive hemostatic agent for use in cardiovascular surgery

EMA validates InterMune's pirfenidone MAA for IPF

EMA validates InterMune's pirfenidone MAA for IPF

FDA's Advisory Committee votes 9-3 to recommend approval of Esbriet for treatment of patients with IPF

FDA's Advisory Committee votes 9-3 to recommend approval of Esbriet for treatment of patients with IPF

NASDAQ halts trading of InterMune's common stock, FDA PADAC to discuss pirfenidone NDA

NASDAQ halts trading of InterMune's common stock, FDA PADAC to discuss pirfenidone NDA

FDA's PADAC meeting to review pirfenidone NDA: InterMune posts briefing documents

FDA's PADAC meeting to review pirfenidone NDA: InterMune posts briefing documents

InterMune seeks European marketing approval for pirfenidone

InterMune seeks European marketing approval for pirfenidone